Figure 1.
Relapse in a patient with cutaneous leishmaniasis (CL) treated with miltefosine (A), classified intially as apparent cure with complete lesion epithelialization (B) but relapse at the second month follow-up visit – recidiva cutis (C and D). Note the nodular lesions in C and D.